Breast Neoplasms: all 12,815 studies
Page 125 of 129. Open to participants first (2,920), then studies with results posted, then the rest; newest registration first within each.
- Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive CancerCompletedNCT00060372Phase 1
- Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast CancerCompletedNCT00060320Phase 3
- High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid TumorsCompletedNCT00060255Phase 2
- Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone MetastasesCompletedNCT00060138Phase 1/2
- Docetaxel in Treating Older Patients With Metastatic Breast, Lung, or Prostate CancerCompletedNCT00059943Phase 2
- Erlotinib and Gemcitabine in Treating Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline and/or a TaxaneCompletedNCT00059852Phase 2
- A Dose-escalation Vaccine Trial in HER2-overexpressing Patients With High-risk Breast CancerCompletedNCT00058526Phase 1
- Trastuzumab and Exemestane in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast CancerWithdrawnNCT00057993Phase 2
- Celecoxib in Preventing Breast Cancer in At-Risk Premenopausal WomenCompletedNCT00056082Phase 2
- Bexarotene in Preventing Breast Cancer in Women at Genetic RiskCompletedNCT00055991Phase 1
- CP-724,714 in Treating Patients With Metastatic Breast CancerCompletedNCT00055926Phase 1
- Bevacizumab and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast CancerCompletedNCT00055861Phase 2
- Combination Chemotherapy in Treating Women With Stage I Breast CancerCompletedNCT00055679Phase 3
- Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast CancerCompletedNCT00054587Phase 3
- Tipifarnib Plus Trastuzumab in Treating Patients With Metastatic Breast CancerWithdrawnNCT00054470Phase 2
- Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast CancerCompletedNCT00054418Phase 3
- Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ or Invasive Breast CancerCompletedNCT00054301Phase 2
- Perifosine in Treating Patients With Recurrent, Refractory, Locally Advanced, or Metastatic Breast CancerCompletedNCT00054145Phase 2
- Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast CancerTerminatedNCT00053911Phase 3
- Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast CancerWithdrawnNCT00053339Phase 3
- Tipifarnib Plus Tamoxifen in Treating Women With Metastatic Breast CancerCompletedNCT00052728Phase 2
- Technetium Tc 99m Sulfur Colloid and Blue Dye In Detecting Sentinel Lymph Nodes in Patients With Breast CancerCompletedNCT00052676Not applicable
- Vaccine Therapy Plus Sargramostim and Chemotherapy in Treating Women With Stage II or Stage III Breast CancerCompletedNCT00052351Phase 2
- Therapy With Docetaxel and ZD1839 for Patients Who Have Advanced Breast CancerCompletedNCT00052169Phase 2
- An Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) in Patients With Breast CancerCompletedNCT00051779Phase 1
- Oral Drug Study In Women With Refractory Metastatic Breast Cancer After First-line or Second-line Herceptin.CompletedNCT00051103Phase 2
- A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast CancerCompletedNCT00051051Phase 2
- A Study of ET-743 (Trabectedin) in Patients With Advanced Breast CancerCompletedNCT00050427Phase 2
- Study of Letrozole Plus Tipifarnib or Placebo in the Treatment of Advanced Breast CancerCompletedNCT00050141Phase 2
- Capecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast CancerTerminatedNCT00049660Phase 2/3
- Gemcitabine Combined With Mistletoe in Treating Patients With Advanced Solid TumorsTerminatedNCT00049608Phase 1
- Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast CancerCompletedNCT00049452Phase 3
- BMS-247550 Plus Capecitabine in Treating Patients With Metastatic Breast CancerStatus unknownNCT00049244Phase 1
- Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast CancerCompletedNCT00049114Phase 2
- Anastrozole and ZD 1839 in Treating Postmenopausal Women With Metastatic Breast CancerCompletedNCT00049062Phase 2
- Phase II Study to Evaluate Tariquidar (XR9576), a Selective MDR-1 Inhibitor, in Chemotherapy Resistant Advanced Breast CancerCompletedNCT00048633Phase 2
- The Sister Study: Genetic and Environmental Risk Factors for Breast CancerCompletedNCT00047970
- Docetaxel and Trastuzumab With or Without Carboplatin in Treating Women With HER2-Positive Breast CancerCompletedNCT00047255Phase 3
- Combination Chemotherapy in Treating Women With Breast CancerCompletedNCT00047099Phase 3
- Acupressure in Treating Nausea in Women Receiving Combination Chemotherapy for Breast CancerCompletedNCT00046865Phase 3
- Study of ABI-007 and Taxol in Patients With Metastatic Breast CancerCompletedNCT00046527Phase 3
- ABI-007 in Taxol Resistant Patients With Metastatic Breast CancerCompletedNCT00046514Phase 2
- Safety and Immunological Response Rate Study of THERATOPE® Vaccine in Metastatic Breast Cancer PatientsCompletedNCT00046371Phase 2
- Celecoxib in Treating Women With Metastatic or Recurrent Breast CancerTerminatedNCT00045591Phase 2
- Imatinib Mesylate in Treating Patients With Metastatic Breast CancerCompletedNCT00045188Phase 2
- Ixabepilone in Treating Patients With Locally Advanced or Metastatic Breast CancerCompletedNCT00045097Phase 2
- Chemotherapy Combined With Gene Therapy in Treating Patients Who Have Stage III or Stage IV Breast CancerCompletedNCT00044993Phase 2
- Evaluation of BAY59-8862 in Taxane-Resistant Metastatic Breast Cancer PatientsCompletedNCT00044525Phase 2
- Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast CancerCompletedNCT00044291Phase 3
- Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic RiskCompletedNCT00043472
- CPG 7909 Plus Herceptin® In Patients With Metastatic Breast CancerCompletedNCT00043394Phase 2
- PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909)CompletedNCT00043368Phase 2
- Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast CancerCompletedNCT00043017Phase 2
- Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the LiverCompletedNCT00041808Phase 1/2
- Safety Study of hMN14 to Treat Either Colorectal or Breast CancerCompletedNCT00041652Phase 1/2
- Comparison of Biomarkers Based on Fine-Needle Aspiration in Women at Increased or Normal Risk of Breast CancerWithdrawnNCT00041353Not applicable
- IH636 Grape Seed Extract in Treating Hardening of Breast Tissue in Women Who Have Undergone Radiation Therapy for Early Breast CancerStatus unknownNCT00041223Phase 2
- Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By SurgeryWithdrawnNCT00041171Phase 3
- Study of 111In-DAC as a Medical Imaging Agent for the Detection of Breast CancerStatus unknownNCT00040430Phase 1
- Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian CancerCompletedNCT00040222
- Open Label, Multicenter, Randomized, Controlled Study of IM or Oral Exemestane (Aromasin) in Postmenopausal WomenTerminatedNCT00040014Phase 2
- Massage Therapy for Cancer-Related FatigueCompletedNCT00039793Phase 2
- Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly PaclitaxelCompletedNCT00039780Phase 3
- Combination Chemotherapy in Treating Women With Breast Cancer Who Have Undergone SurgeryStatus unknownNCT00039546Phase 3
- Sulindac and Docetaxel in Treating Women With Metastatic or Recurrent Breast CancerCompletedNCT00039520Phase 2
- Trastuzumab and Flavopiridol in Treating Patients With Metastatic Breast CancerTerminatedNCT00039455Phase 1
- Positron Emission Tomography Before Surgery in Evaluating Women With Primary or Recurrent Breast CancerCompletedNCT00039286Phase 1
- Intravenous Interleukin-4 PE38KDEL Cytotoxin in Treating Patients With Recurrent or Metastatic Kidney Cancer, Non-Small Cell Lung Cancer, or Breast CancerCompletedNCT00039052Phase 1
- Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast CancerCompletedNCT00038402Phase 3
- Safety, Efficacy and Pharmacokinetic Between Capecitabine and Exisulind in Metastatic Breast Cancer PatientsCompletedNCT00037609Phase 1/2
- Study of Health Promotion in Patients With Early-Stage Breast or Prostate CancerCompletedNCT00037024Not applicable
- Microwave Thermotherapy in Treating Women With Stage I or Stage II Breast CancerStatus unknownNCT00036998Phase 2
- Combination Chemotherapy With or Without Microwave Thermotherapy Before Surgery in Treating Women With Locally Advanced Breast CancerStatus unknownNCT00036985Phase 2
- Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast CancerCompletedNCT00036868Phase 2
- Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced CancerCompletedNCT00036790Phase 1
- Isoflavones in Treating Women Who Have Breast Cancer and Are Planning to Undergo Mastectomy or LumpectomyTerminatedNCT00036686Not applicable
- A Randomized, Placebo-Controlled Trial of BMS-275291 Given Daily for 12 Months to Women With Stage 1c-IIIA Breast Cancer Receiving Adjuvant Chemotherapy and/or Hormonal TherapyTerminatedNCT00036621Phase 2
- Chemotherapy Related Anemia in Patients With Non-Myeloid MalignanciesCompletedNCT00036023Phase 2
- Phase 2 Study of TLK286 in Metastatic Breast CancerCompletedNCT00035841Phase 2
- EPO906 Therapy in Patients With Advanced Breast CancerCompletedNCT00035126Phase 2
- This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Metastatic Breast CancerCompletedNCT00034918Phase 2
- A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic CancerCompletedNCT00034827Phase 2
- A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer.CompletedNCT00034489Phase 2
- Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2CompletedNCT00034281Phase 1
- Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.CompletedNCT00034125Phase 3
- Combination Chemotherapy in Treating Women With Resected Breast CancerStatus unknownNCT00033683Phase 2
- Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer SurgeryCompletedNCT00033397
- CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung CancerCompletedNCT00033384Phase 2
- Indole-3-Carbinol in Preventing Breast Cancer in Nonsmoking Women Who Are at High Risk For Breast CancerCompletedNCT00033345Phase 1
- Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Breast CancerCompletedNCT00032136Phase 3
- Capecitabine and Paclitaxel in Treating Patients With Metastatic Breast CancerCompletedNCT00031876Phase 1/2
- Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast CancerCompletedNCT00031850Not applicable
- Raloxifene With or Without Exercise Compared With Exercise Alone in Women Who Have Been Previously Treated for Breast CancerCompletedNCT00031811Not applicable
- S9832: Effectiveness of Telephone Counseling By Breast Cancer Survivors on the Well-Being of Women With Recurrent Breast CancerCompletedNCT00031772Not applicable
- Soy Protein Supplement In Treating Hot Flashes in Postmenopausal Women Receiving Tamoxifen for Breast DiseaseCompletedNCT00031720Phase 2
- 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)CompletedNCT00031681Phase 1
- Filgrastim or Pegfilgrastim in Preventing Neutropenia in Women Receiving Chemotherapy Following Surgery for Breast CancerStatus unknownNCT00030758Phase 4
- Decitabine in Treating Patients With Advanced Solid TumorsCompletedNCT00030615Phase 1
- Erlotinib in Treating Patients With Locally Advanced or Metastatic Breast CancerCompletedNCT00030537Phase 2
- Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionCompletedNCT00030498Phase 1